Mixed Final Ruling In Nevro, Boston Sci Patent Spat
Executive Summary
A California federal judge delivered a mixed verdict in a patent dispute between Nevro Corp. and Boston Scientific. The court said that some of Nevro's claims were patent-eligible, but further ruled that Boston Scientific had not infringed those patents.
You may also be interested in...
Nevro, Boston Sci Settle Spine-Stim Patent Dispute
Nevro and Boston Scientific have resolved a patent dispute involving spinal cord stimulation technologies.
Nevro May Lose Pain-Stim Patent Case Against Boston Scientific
A California judge has issued a tentative ruling favoring Boston Scientific in patent litigation between the company and Nevro. But the negative impact of the ruling on Nevro may be limited, analysts say.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.